Johnson & Johnson Earnings Beat Boosted by Hepatitis Drug

Shares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earn

http://www.wltx.com/video/3675891329001/1/Johnson--Johnson-Earnings-Beat-Boosted-by-Hepatitis-Drughttp://cdn.newslook.com/0f/0f8bba3623316c411ab8f5848cc6ee73/images/frame_ext.jpgJohnson & Johnson Earnings Beat Boosted by Hepatitis DrugShares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earntheStreet.comJNJTSCMNew YorkincFinanceyoutubeYahoo!newslookJohnson & JohnsonUnited States of America01:16